Vaxart, Inc(NASDAQ:VXRT) 
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial...
Website: http://vaxart.com
Founded: 2004
Full Time Employees: 30
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.38
H 0.40
L 0.34
C 0.34
V 2,941,505
10EMA 0.34
20EMA 0.34
60EMA 0.34
120EMA 0.34
250EMA 0.34